WHITE PAPER
Pharmaceutical Industry Transparency Resourcing: Time to consider outsourcing?
Aug 02, 2022

Life sciences companies of all sizes face an interesting dilemma. On one hand, 'The Great Resignation' is depleting in-house expertise across several functional areas, including transparency reporting. On the other, eight years have passed since the first submission deadline under the Sunshine Act. The entire submission process has now become relatively routine. Could this be the moment to consider outsourcing of this non-core activity to an experienced partner, freeing up internal expertise for more strategic efforts year-round? This white paper takes a look at key considerations for deciding whether to outsource this function.

Related solutions

Contact Us